Skip to main content
Presentation
Optimizing a Novel, Serum-Free, Three-Dimensional Culture System of Primary Human Osteoarthritic Chondrocytes: A Clinically Relevant Platform to Test and Develop Osteoarthritis Therapeutics
The FASEB Journal (2018)
  • Hannah Ruth Popper, Bio‐Medical SciencesPCOMPhiladelphiaPA
  • Andrea Lynn Buckley, Bio‐Medical SciencesPCOMPhiladelphiaPA
  • Patrisia Mattioli, Bio‐Medical SciencesPCOMPhiladelphiaPA
  • LaBraya Milton, Orthopedic SurgeryCooper University HospitalCamdenNJ
  • Firas Alsaid, Bio‐Medical SciencesPCOMPhiladelphiaPA
  • Lawrence Miller, Orthopedic SurgeryCooper University HospitalCamdenNJ
  • Tae‐Won Kim, Orthopedic SurgeryCooper University HospitalCamdenNJ
  • Mark Pollard, Orthopedic SurgeryCooper University HospitalCamdenNJ
  • Kathryn Behling, Biomedical SciencesCooper School of Medicine of Rowan UniversityCamdenNJ
  • Abdulhafez Selim, Bio‐Medical SciencesPCOMPhiladelphiaPA
  • Marina D'Angelo, Bio‐Medical SciencesPCOMPhiladelphiaPA
Publication Date
April 1, 2018
DOI
10.1096/FASEBJ.2018.32.1_SUPPLEMENT.640.6
Citation Information
Hannah Ruth Popper, Andrea Lynn Buckley, Patrisia Mattioli, LaBraya Milton, et al.. "Optimizing a Novel, Serum-Free, Three-Dimensional Culture System of Primary Human Osteoarthritic Chondrocytes: A Clinically Relevant Platform to Test and Develop Osteoarthritis Therapeutics" The FASEB Journal Vol. 32 (2018)
Available at: http://works.bepress.com/marina_dangelo/53/